FTCM
CEROW

Fir Tree Capital Management’s CERo Therapeutics Warrants CEROW Stock Holding History

Fir Tree Capital Management’s Portfolio CEROW Stock Details CEROW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-125,000
Closed -$13K – 560
2022
Q2 		$13K Hold
125,000
– – ﹤0.01% 640
2022
Q1 		$27K Hold
125,000
– – ﹤0.01% 675
2021
Q4 		$54K Buy
+125,000
New +$57.6K ﹤0.01% 666

Other funds holding CEROW

MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Fir Tree Capital Management's CEROW Position: Q3 2022 in Review

Fir Tree Capital Management sold out of CERo Therapeutics Warrants (CEROW) in Q3 2022, closing a stake of 125,000 shares — an estimated $13K sold.

Fir Tree Capital Management first reported a position in CEROW in Q4 2021 and held it in 3 quarters. The position peaked at $54K in Q4 2021. 43 funds tracked by Wall St. Rank hold CEROW as of Q3 2022.

  • Fir Tree Capital Management reported no remaining CERo Therapeutics Warrants position as of Q3 2022 after selling out during the quarter.
  • Fir Tree Capital Management sold 125,000 CERo Therapeutics Warrants shares in Q3 2022, an estimated $13K.
  • Fir Tree Capital Management first reported a position in CERo Therapeutics Warrants in Q4 2021 and held it in 3 quarters.
  • Fir Tree Capital Management's CERo Therapeutics Warrants position peaked at $54K in Q4 2021.
  • 43 funds tracked by Wall St. Rank held CERo Therapeutics Warrants as of Q3 2022.

Based on Fir Tree Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.